BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lactobacillus plantarum {L. plantarum} - Candidatus Amulumruptor |
👶
Lactobacillus plantarum HF02 alleviates lipid accumulation and intestinal microbiota dysbiosis in high-fat diet-induced obese mice. Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 103 Issue 9 Pages: 4625-4637 Pub: 2023 Jul Epub: 2023 Mar 18 Authors Chen H , Zhao H , Qi X , Sun Y , Ma Y , Li Q , Publication |
| Lactobacillus plantarum {L. plantarum} - Candidatus Amulumruptor |
👶
Lactobacillus plantarum and Bifidobacterium bifidum alleviate dry eye in mice with exorbital lacrimal gland excision by modulating gut inflammation and microbiota. Food & function (Food Funct ) Vol: 12 Issue 6 Pages: 2489-2497 Pub: 2021 Mar 21 Epub: 2021 Mar 3 Authors Yun SW , Son YH , Lee DY , Shin YJ , Han MJ , Kim DH , Publication |
| Lactobacillus plantarum {L. plantarum} - Candidatus Amulumruptor |
👶
The antioxidant strain Lactiplantibacillus plantarum AS21 and Clostridium butyricum ameliorate DSS-induced colitis in mice by remodeling the assembly of intestinal microbiota and improving gut functions. Food & function (Food Funct ) Vol: 15 Issue 4 Pages: 2022-2037 Pub: 2024 Feb 19 Epub: 2024 Feb 19 Authors Li W , Zhang Y , Chen M , Guo X , Ding Z , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
